Skip to main content

Table 2 Comparison of IL28B genotype and allele between non-diabetic and diabetic

From: Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes

Variable Group I a & b
Non-diabetic (n = 80)
Group II a & b
Diabetic (n = 80)
Total
(n = 160)
χ2 p value OR (95%CI)
Genotype  
CC 29 (36.3%) 11 (13.7%) 40 (25%) 6.14 0.03* 1
CT 35 (43.7%) 47 (58.8%) 82 (51.3%) 3.01(1.31–6.88)
TT 16 (20.0%) 22 (27.5%) 38 (23.7%) 2.02(0.79–5.18)
Allele  
C 94 (58.7%) 76 (47.5%) 85 (53.1%) 2.48 0.04* 1.45
(1.09–2.5)
T 66 (41.3%) 84 (52.5%) 75 (46.9%)
  1. X2 = Chi-square test *: significant p < 0.05 OR: odds ratio, CI: confidence interval